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Clonal Acquisition of the Ly49A NK Cell
Receptor Is Dependent on the
trans-Acting Factor TCF-1
killer gene complex (NKC), a region on the distal part of
mouse chromosome 6 that encodes a significant num-
ber of NK cell receptors (Brown et al., 1997a, 1997b).
While Ly49s are homodimeric, type II lectin-like recep-
tors, human NK cells use a set of structurally distinct
Werner Held,*³ BeÂ atrice Kunz,*
Bente Lowin-Kropf,* Marc van de Wetering,²
and Hans Clevers²
*Ludwig Institute for Cancer Research
Lausanne Branch
immunoglobulin-like receptors for the recognition ofUniversity of Lausanne
classical MHC class I molecules (Colonna and Samar-155 Chemin des Boveresses
idis, 1995). These receptors recognize specific alleles1066 Epalinges
of class I heavy chains that form a trimolecular complexSwitzerland
with b2m and peptide ( Malnati et al., 1995). The Ly49A²Department of Immunology
receptor binds to Dd or Dk (but, e.g., not to Db or Kd)University Hospital
class I molecules (Karlhofer et al., 1992). Consistent withHeidelberglaan 100
missing self recognition, NK cells expressing the Ly49A3584 CX Utrecht
receptor are inhibited when encountering the relevantThe Netherlands
ligands on target cells (Karlhofer et al., 1992). Other Ly49
receptors have distinct, yet often overlapping, MHC
specificities (reviewed by Raulet et al., 1997).Summary
Irrespective of the structural differences, transduction
of an inhibitory signal by either the Ly49 or the KIR familyFamilies of clonally expressed major histocompatibil-
receptors is based on the so-called immunoreceptor
ity complex (MHC) class I±specific receptors provide
tyrosine-based motif (ITIM) (V/IxYxxL) present in the cy-
specificity to and regulate the function of natural killer
toplasmic tails. Phosphorylation of the tyrosine residue
(NK) cells. One of these receptors, mouse Ly49A, is
in the ITIM results in the recruitment of the tyrosine
expressed by 20% of NK cells and inhibits the killing
phosphatases SHP-1 and SHP-2. The former is clearly
of H-2Dd but not Db-expressing target cells. Here, we involved in transducing the inhibitory signal that aborts
show that the trans-acting factor TCF-1 binds to two NK cell cytotoxicity (Burshtyn et al., 1996; Nakamura
sites in the Ly49A promoter and regulates its activity. et al., 1997). Intriguingly, some MHC class I±specific
Moreover, we find that TCF-1 determines the size of receptors lack a consensus ITIM. They are associated
the Ly49A NK cell subset in vivo in a dosage-depen- noncovalently with a small homodimeric molecule, DAP-
dent manner. We propose that clonal Ly49A acquisi- 12, that mediates an activating signal upon receptor
tion during NK cell development is regulated by TCF-1. cross-linking (Lanier et al., 1998). Indeed, such receptors
enable positive non-self-MHC reactivity by NK cells (Na-
kamura et al., 1999) and thus extend the modes of NKIntroduction
cell reactivity beyond the one predicted by the missing-
self hypothesis. Expression of Ly49 receptors is ob-Natural killer (NK) cells can kill target cells that lack some
served on NK cells, NK1.1-positive and -negative T cells,or all major histocompatibility complex (MHC) class I
and a few T cell lymphomas. In sharp contrast to antigenmolecules on their surface. This mode of reactivity has
receptors expressed by T or B cells, a single NK cellbeen termed ªmissing selfº recognition (Ljunggren and
can express multiple MHC receptors. In fact, each NKKarre, 1990). Considerable progress has been made in
cell displays a selection of the available Ly49 receptors.understanding the molecular basis for missing self rec-
Self-MHC-reactive and nonreactive receptors are oftenognition. It is now well accepted that NK cells can be
coexpressed, suggesting that receptor acquisition oc-activated to kill a target cell via multiple different recep-
curs randomly and is not stringently directed by thetor-ligand interactions. However, the NK cell's activation
host's MHC class I (stochastic expression). Detailed ex-is prevented when inhibitory, MHC class I±specific re-
pression analyses revealed that coexpression of Ly49ceptors interact with their ligands on target cells. The
receptors in single NK cells is observed at frequencieslysis of MHC-deficient cells is therefore based on the
that are expected when receptors are expressed inde-NK cell's failure to receive an inhibitory signal via MHC
pendently and coexpression coincides (independentreceptors (reviewed by Lanier et al., 1997).
expression) (Held et al., 1996). The product of the fre-The molecular basis for missing self recognition started
quencies of individual receptors predicts in fact fairlyto emerge following the identification of MHC class I±spe-
accurately the frequency of coexpressors (productscific inhibitory receptors such as mouse Ly49A (Karl-
rule) (Raulet et al., 1997). Significantly, even thoughhofer et al., 1992). It turned out that Ly49A defines a
mouse and human NK cell receptors for classical classreceptor family that currently comprises fourteen highly
I molecules are structurally distinct, their expressionrelated genes (Ly49a-n) (Wong et al., 1991; Brennan et
seems to be governed by similar rules (Valiante et al.,
al., 1994; Smith et al., 1994; McQueen et al., 1998). These
1998).
genes are tightly linked in a subregion of the natural
MHC class I±dependent cellular events somehow
adapt the NK cell pool to their MHC environment (Ohlen
et al., 1989). With regard to Ly49, MHC-dependent ef-³ To whom correspondence should be addressed (e-mail: wheld@
isrec.unil.ch). fects on single receptor usage as well as positive and
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negative associations between distinct Ly49 receptors pathway is implicated in malignant transformation (Kori-
nek et al., 1997; Rubinfeld et al., 1997). In addition, forthat deviate from the products rule are observed in nor-
mal mice (Held et al., 1996; Raulet et al., 1997). These T cell receptor (TCR) a enhancer function, TCF-1 and
LEF-1 perform a context dependent, architectural role,effects may in part reflect processes that prevent the
emergence of autoaggressive NK cell clones. Indeed, it which does not depend on b-catenin binding (van de
Wetering et al., 1996; Hsu et al., 1998). Here, we showis thought that NK cells that fail to express at least
one self-MHC-specific receptor do not develop and/ that TCF-1 regulates the Ly49A promoter and directs
the clonal acquisition of the Ly49A receptor during NKor functionally mature. The independent and random
expression together with the ligand selectivity of MHC cell development.
receptors provides the NK cell compartment with con-
siderable clonal heterogeneity. This may enable NK cells Results
to also react to relatively subtle perturbations in a target
cell's MHC makeup, such as the absence of a single Analysis of the Ly49A Promoter Region
class I allele. These alterations may result from mutation, The molecular mechanisms that control Ly49 gene ex-
transformation, or infection, and thus indicate the pres- pression and establish clonally diverse Ly49 receptor
ence of diseased cells. expression are not understood. The observation that
Very little is known about the molecular mechanisms DNA recombination is not involved (data not shown)
that regulate clonally diverse Ly49 expression and thus suggests transcriptional control mechanisms. This has
establish an MHC-specific NK cell receptor repertoire. prompted us to study the Ly49A promoter. Indeed, tran-
NK cells are bone marrow derived, and the marrow mi- sient transfection of 1.1 kb of immediate upstream se-
croenvironment plays an important role in their genera- quence of the Ly49A gene confers strong activation of
tion (Ogasawara et al., 1998; Williams et al., 1998). The a luciferase reporter in certain T cell lymphomas (such
development of NK cells can be initiated in vitro from as EL-4 or RMA), which correlates with the expression
multipotent bone marrow precursor cells using cyto- of endogenous Ly49A by these cells (Figure 1A). Other
kines (interleukin-6, 27, and 215, and flt3 ligand). How- tumor cell lines or T cell lymphomas including one (CTLL)
ever, this is not sufficient to initiate expression of Ly49 that expresses the NKC encoded NK1.1 receptor were
receptors (Williams et al., 1998). Ly49 receptor acquisi- unable to support efficient reporter gene activity. Similar
tion may thus be a developmentally regulated process results were obtained with a shortened (0.4 kb) Ly49A
that requires specialized factors produced by and/or promoter fragment (data not shown). Upon examination
direct interactions with the bone marrow microenviron- of the relevant sequence, we noticed two consensus
ment. Among mature NK cells, the expression of individ- binding sites for TCF/LEF proteins (CAAAGT/AT/A, de-
ual Ly49 receptors is observed on subsets of 20%±50% noted site I and II) within 100 bp of the transcriptional
of NK cells. Intriguingly, Ly49 receptors are expressed start site (11) (Figure 1B). Two additional, yet noncon-
from a single allele, whereby individual NK cells can sensus, TCF/LEF binding sites were previously noted
express either the maternal or the paternal allele. Occa- further upstream (Kubo et al., 1993).
sional NK cells, however, simultaneously express both
alleles. In fact, the frequency by which such cells are
TCF-1 Binds to the Ly49A Promoterobserved is consistent with an independent and sto-
To determine whether TCF/LEF factors are able to bindchastic activation of individual alleles of Ly49 genes
to the Ly49A promoter, we performed electrophoretic(Held et al., 1995; Held and Raulet, 1997a; Held and
mobility shift assays (EMSA) using in vitro transcribedKunz, 1998). However, while the underlying mechanism
and translated TCF-1. An excess of a 222 bp Ly49Ais not known, it is clear that the patterns of Ly49 expres-
promoter fragment, which includes the two TCF/LEFsion as well as NK cell development are not dependent
binding sites I and II, efficiently competed for TCF-1on gene recombination events. They are established
binding to a radio-labeled oligo nucleotide probe thatnormally in RAG-1-deficient mice (Shinkai et al., 1992;
contains an optimal TCF/LEF site (Figure 2). Ly49A pro-Held et al., 1999). Ly49 receptor expression is thus most
moter fragments in which only one site was presentlikely transcriptionally controlled. In order to begin to
retained their competitor capacity, although site I wasidentify trans-acting factors involved in Ly49 gene ex-
more efficient than site II. In contrast, the competitorpression, we took the approach to analyze the Ly49A
activity was essentially lost upon elimination of bothpromoter region. This has led us to identify TCF-1 as a
sites. Virtually identical results were obtained with nu-trans-acting factor involved in Ly49A expression.
clear extracts from EL-4 thymoma cells (data notTCF-1 and the closely related LEF-1 (as well as TCF-3
shown). The data thus show that TCF/LEF factors areand TCF-4) are high mobility group (HMG) proteins that
able to bind to the Ly49A promoter in a sequence-spe-were discovered as proteins binding to specific lymphoid
cific manner at two distinct sites close to the transcrip-enhancers (Travis et al., 1991; van de Wetering et al.,
tional start site.1991). Recent experiments have established that TCF/
LEF factors can associate with b-catenin in response
to signaling through the wingless/wnt pathway, thereby Ly49A Promoter Activity Is Dependent
regulating cell fate decisions (Behrens et al., 1996; Mo- on TCF/LEF Sites
lenaar et al., 1996; Brannon et al., 1997; Riese et al., In addition to binding, we directly assessed the depen-
1997) and proliferation (He et al., 1998; Korinek et al., dence of Ly49A promoter activity on the two TCF/LEF
1998; Tetsu and McCormick, 1999). Not surprisingly, binding sites using transient transfection of the Ly49A1
thymoma EL-4. Mutation of TCF/LEF site II (but not I)therefore, deregulation of the wingless/wnt signaling
TCF-1-Dependent Ly49A Acquisition
435
Figure 1. Activity and Sequence Analysis of
the Ly49A Promoter and TCF-1 Expression in
NK Cells
(A) One kilobase of 59 upstream sequence of
the Ly49A gene was fused to a luciferase (luc)
reporter gene construct and transiently trans-
fected into various tumor cell lines. Specific
activity was determined relative to a promot-
erless luc construct. Data indicate mean of
fold-specific induction (6 SD) of three or
more independent experiments. Ly49A ex-
pression was determined using flow cytome-
try. TCF-1 expression has been assessed us-
ing Northern blot. T cell lymphoma, T; B cell
lymphoma, B; mastocytoma, M; epithelial
cell line, Ep.; NA, not applicable because the
cell line is not mouse; ND, not determined.
(B) Two consensus TCF/LEF binding sites
(denoted I and II) are located close to the
transcriptional start site (11) in the Ly49A
promoter. Two additional yet not consensus
sites located further upstream were pre-
viously noted (Kubo et al., 1993).
(C) Northern blot analysis of TCF-1 mRNA.
Total cellular RNA from L cells (L), Con A stim-
ulated T cells (T), and interleukin 2 expanded
NK cells (NK) was hybridized with a TCF-1
cDNA probe (upper panel, 5 days exposure),
stripped, and reprobed with a GAPDH probe
(lower panel, 1 day exposure).
significantly diminished reporter gene activity. The elimi- indicate that TCF/LEF function in the context of the
nation of both sites further reduced the reporter gene Ly49A promoter does not require b-catenin. In fact,
activity to levels that are only slightly above those ob- Ly49A promoter activity in EL-4 cells is observed in the
served in A20 B cells (Figure 3A). Similar results were absence of intracellular free b-catenin. This was shown
obtained in stable transfection experiments using the by transient transfections with TOP (and the control
corresponding green fluorescent protein (GFP) reporter FOP) reporter constructs into EL-4 cells. The TOP re-
constructs (data not shown). TCF/LEF binding sites are porter contains three optimal TCF/LEF binding sites,
thus required for Ly49A promoter activity in EL-4 cells. (while FOP has mutant sites) upstream of a minimal
To see whether TCF/LEF binding regulates Ly49A pro- c-Fos promoter. Its activity depends on the binding of
moter activity, we have transfected EL-4 cells with wild- TCF/LEF factors and their association with b-catenin
type or mutant Ly49A reporters together with a TCF-1 (Korinek et al., 1997). As shown in Figure 3C, TOP and
expression construct that lacks a b-catenin interaction
FOP are equally active, suggesting that there is no con-
site (DN TCF-1). This TCF-1 isoform activates transcrip-
stitutive b-catenin-TCF/LEF association in EL-4. How-tion from a TCRa enhancer construct (van de Wetering
ever, TOP is active upon cotransfecting with b-catenin,et al., 1996) and inhibits TCF/LEF-b-catenin-dependent
suggesting that intracellular free b-catenin and not func-transcription (data not shown). As shown in Figure 3B,
tional TCF/LEF is lacking in EL-4 cells. The activity ofthe activity of the wild-type promoter was increased in
the Ly49A promoter in EL-4 cells is thus dependentthe presence of the TCF-1 expression plasmid, while the
on TCF-1 (and/or LEF-1) but independent of b-cateninactivity of the mutant Ly49A promoter was not signifi-
association. We have thus assessed the role of TCF-1cantly altered. TCF-1 binding to consensus TCF/LEF
in NK cell development and Ly49A gene expression insites in the Ly49A promoter therefore regulates its activ-
ity. While the data do not exclude a role for LEF-1, they vivo using TCF-1-deficient mice.
Immunity
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Figure 2. TCF-1 Binds the Ly49A Promoter in Electrophoretic Mobil-
ity Shift Assays
A radio-labeled TCF/LEF site containing oligo nucleotide is bound
by recombinant TCF-1 (lane 2) but not an irrelevant protein (lane
1) in electrophoretic mobility shift assays. The specific binding is
competed by an excess of Ly49A promoter fragment (PstI to EcoRV):
wild-type fragment (lanes 3±5), TCF/LEF site I mutant (lanes 6±8),
site II mutant (lanes 9±11), or both sites mutant (12±14). A molar
competitor excess of 8-, 25-, and 75-fold, respectively, was used
for each fragment.
TCF-1-Deficient Mice Essentially Lack
Ly49A1 NK Cells
Besides T cell lymphomas, TCF-1 expression is ob-
served in T cells of adult mice (Oosterwegel et al., 1993;
Verbeek et al., 1995; Hattori et al., 1996). We have de-
tected TCF-1 mRNA also in interleukin-2 expanded NK
cells using Northern blot analysis (Figure 1C). The lack
of TCF-1 in mice prevents the development of postnatal
thymic T cells (Verbeek et al., 1995) and certain NK T
cell subsets (Ohteki et al., 1996). In contrast, NK cell
development is relatively unimpaired based on normal
percentages and absolute numbers of splenic or liver Figure 3. Regulation of Ly49A Promoter Activity
NK cells (Figure 4; data not shown). Only the percentage (A) Reporter gene assays were done in EL-4 (white bars) and A20
of NK1.11 CD32 bone marrow NK cells is significantly (black bars) lymphoma cells using the EcoRI±EcoRV fragment of
the wild-type Ly49A promoter, the same construct but TCF/LEF site(7-fold) reduced in TCF-12/2 (1.2 6 0.8% of lymphoid,
II mutated, site I mutated, or both sites mutated. Fold induction ofnylon wool nonadherent cells) compared to TCF-11/2
luciferase (luc) activity was determined relative to a promoterless(9.0 6 3.1%) or TCF-11/1 (8.4 6 3.3%) mice. While these
luc construct. Data indicate mean of fold-specific induction (6 SD)
latter observations may reflect a reduced capacity of of four or more independent experiments.
TCF-12/2 progenitor cells to expand (Schilham et al., (B) Reporter gene assays in EL-4 cells using wild-type or double
1998), NK cells seem to accumulate to generate an intact mutant Ly49A promoter in the presence of DN TCF-1 (lacking a
b-catenin interaction site) or empty pEF Boss expression plasmid.peripheral NK cell compartment.
Data were generated as described above.Despite the normal numbers of NK cells in spleens of
(C) EL-4 cells were transiently transfected with reporters containingTCF-1-deficient mice, the size of the Ly49A NK cell sub-
three copies of an optimal (TOP) or mutant (FOP) TCF/LEF motif
set is dramatically (20-fold) reduced (from 20.4 6 4.8% upstream of a minimal c-Fos promoter driving luciferase expression.
in wild-type to 1.1 6 0.3% in TCF-1 mutant mice) (Figure Both reporters were tested in the presence of a b-catenin or empty
4; Table 1). The same observation was made among pCDNA expression plasmid. Data indicate luc activity relative to
TOP (which is assigned the value 1) of four independent experimentsliver, blood, and bone marrow NK cells (Table 1; data
(6 SD).not shown). Their virtual absence from bone marrow,
where NK cells develop (Moore et al., 1996), suggests
that TCF-1 deficiency affects an early event in the devel-
opment of Ly49A-expressing NK cells. Moreover, the to TCF-12/2 mice (14- and 19-fold, respectively, in two
independent experiments) (Figure 5). This reduction inLy49A phenotype of TCF-12/2 NK cells is unaffected
by their culture in high doses of interleukin-2 (data not Ly49A message levels is in good agreement with the
reduced frequency of Ly49A1 NK cells in TCF-12/2 miceshown), and the level of Ly49A mRNA is comparable to
the proportion of TCF-12/2 NK cells that express Ly49A (20- and 15-fold in the two respective experiments). The
failure to detect normal percentages of Ly49A1 NK cells(Figure 5). The latter was borne out using a semiquantita-
tive PCR approach with primers specific for Ly49A and in TCF-12/2 mice is thus evident at the level of Ly49A
mRNA.control NKRP-1C cDNA. Relative to NKRP-1C, Ly49A
message was specifically more abundant in interleu- Compared to Ly49A-negative, 129/Sv-derived NK cells,
a low, but significant number of Ly49A-expressing NKkin-2 expanded splenic NK cells from TCF-11/1 compared
TCF-1-Dependent Ly49A Acquisition
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Figure 4. Analysis of TCF-1 Mutant Mice:
Presence of NK Cells in Different Organs and
Expression of Ly49A in Splenic NK Cells
(A) Absolute numbers of NK cells among ny-
lon wool nonadherent spleen and bone mar-
row cells as well as liver mononuclear cells
in different TCF-1 genotype mice. Numbers
for bone marrow represent NK cells residing
in femur and tibia of the two hind legs.
(B) Upper panel: nylon wool nonadherent
spleen cells were stained with anti-CD3 and
DX5 mAbs. Numbers indicate percent CD32
DX51 (6 SD) NK cells in spleens of three to
eight mice. Middle panel: percent NK1.11
cells (6 SD) among CD32 DX51 cells. Positive
NK1.1 staining ensures the presence of a B6-
derived NK gene complex (NKC), which har-
bors the polymorphic Ly49 gene cluster.
Lower panel: percent Ly49A1 NK cells (6 SD)
among CD32 DX51 NK cells. The mean fluo-
rescence intensity (MFI) of Ly49A staining is
indicated relative to the levels on TCF-11/1
B6 NK cells (value 5 100). MFIs of TCF-11/2
(96 6 8) and TCF-12/2 (93 6 9) NK cells are
not significantly different. Ly49A-negative NK
cells of 129/Sv mice served as a staining
control.
cells is detected in TCF-1-deficient mice (Figure 4; Table NK cells and among NK T cells (data not shown). Im-
portantly, B, T, NK T, and NK cell development is nor-1). Surprisingly, upon reintroduction of a single func-
tional TCF-1 allele, an intermediate frequency of Ly49A1 mal in TCF-11/2 mice, suggesting that the effect on
the Ly49A NK cell subset is not the consequence ofNK cells is observed. A similar TCF-1 gene dosage de-
pendence was observed among liver and bone marrow an otherwise impaired lymphoid development. Clearly
Table 1. Ly49 Receptor Expression among TCF-1-Deficient NK Cells
MHC TCF-11/1 TCF-11/2 TCF-12/2 TCF-11/1
Organ Receptor Function Specificity B6a, H-2b B6, H-2b B6, H-2b 129, H-2b
Spleen Ly49A Inhib. d 20.4 6 4.8b (8)c 9.8 6 1.5d (8) 1.1 6 0.3d (9) 0.1 6 0.1 (3)
Spleen Ly49C/I Inhib. b, d 51.5 6 4.4 (5) 61.6 6 8.2f (6) 60.2 6 11.1 (7) 0.3 6 0.5 (3)
Spleen Ly49C Inhib. b, d 26.7 6 4.4 (3) 27.9 6 4.3 (3) 30.0 6 3.7 (3) NDg
Spleen Ly49D Activ. d 54.2 6 8.4 (4) 39.4 6 2.2e (3) 17.8 6 1.4d (3) 77.5 6 1.9 (3)
Spleen Ly49G2 Inhib. d 52.1 6 5.1 (4) 52.9 6 3.0 (3) 68.9 6 2.3d (6) 58.6 6 3.7 (3)
Liver Ly49A Inhib. d 13.8 6 1.5 (4) 8.9 6 1.3e (3) 1.2 6 0.5d (3) ND
BMh Ly49A Inhib. d 17.9 6 4.0 (3) 10.6 6 2.6e (4) 1.5 6 1.3d (5) ND
a Origin of the NK complex: B6, C57BL/6; 129, 129/Sv.
b Numbers represent percent Ly491 cells (6 SD) among DX51 CD32 splenic NK cells. Liver and bone marrow NK cells were gated NK1.11 CD32.
c The number of determinations.
d Statistically significant difference (p , 0.001, Student's t-test) compared to B6 TCF-11/1 and where applicable to B6 TCF-11/2.
e Significant difference (p , 0.02, Student's t-test) compared to B6 TCF-11/1.
f Significant difference (p , 0.05, Student's t-test) compared to B6 TCF-11/1.
g ND, not determined.
h BM, bone marrow.
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Figure 5. Expression of Ly49A mRNA in TCF-1-Deficient NK Cells
Ly49A mRNA levels between TCF-1-deficient and wild-type NK cells
were compared using a semiquantitative reverse transcriptase poly-
merase chain reaction (RT-PCR) approach. Complementary DNAs
from adherent, interleukin-2 expanded NK cells were serially diluted
before amplification with Ly49A- and NKRP-1C-specific primers.
PCR products were hybridized to radio-labeled Ly49A- and NKRP-
1-specific oligos, respectively.
therefore the effect on NK cell development in general
is separable from the specific effect on the Ly49A NK
cell subset.
The presence of occasional Ly49A NK cells in
TCF-12/2 mice suggests that normal Ly49A expression
levels (as opposed to frequencies of cells) are not de-
pendent on TCF-1. This is evident from the mean fluores-
cence intensity (MFI) of Ly49A1 NK cells (using mAb
JR9-318) that is identical among the different TCF-1
genotype mice (Figure 4). Therefore, TCF-1 is required
for the acquisition of Ly49A, but it is apparently dispens-
able for normal Ly49A cell surface expression once its
expression is initiated. Figure 6. TCF-1 Deficiency Results in an NK Cell Autonomous De-
fect to Express the Ly49A Gene
Lethally irradiated TCF-11/1 (CD45.22) recipient mice were reconsti-TCF-1 Deficiency Selectively Affects Ly49
tuted with equal numbers of TCF-11/1 (CD45.22) and TCF-1 mutantReceptor Usage
(CD45.21) bone marrow cells (5 3 106 cells total). The density plot
Since Ly49A is a member of a gene family that contains depicts expression of CD3 versus NK1.1 among total, nylon wool
highly homologous, clonally distributed MHC class I re- nonadherent spleen cells of chimeric mice. Histograms show the
ceptors, TCF-1 may be important for the acquisition contribution of CD45.21 (TCF-1 mutant) cells (6 SD) in five chimeras
to the T cell lineage (R1), to CD32 NK1.12 cells (. 90% B cells; dataof additional Ly49 receptors. Indeed, the frequency of
not shown) (R2), and to NK cells (R3). Among NK cells, histogramsLy49D1 NK cells was significantly reduced (3-fold) in
show percent Ly49A1 cells (6 SD) in CD45.22 (wild-type) or CD45.21TCF-12/2 mice, and an intermediate size Ly49D subset
(TCF-1 mutant) NK cells.
was observed in TCF-1 heterozygotes (Table 1). Other
effects include a significantly increased frequency of
Ly49G21 NK cells. While Ly49C1 cells were equally YAC-1 tumor target cells. In addition, wild-type and TCF-
1-deficient NK cells produce similar amounts of IFNgabundant among the different TCF-1 genotype mice, the
frequency of Ly49C/I1 cells was marginally increased, following stimulation with anti-NK1.1 mAbs PK136 or
3A4 (data not shown). We therefore conclude thatsuggesting perhaps an effect on Ly49I-expressing NK
cells. TCF-1 deficiency thus modifies the sizes of several TCF-12/2 NK cells are functionally mature.
Ly49-defined NK cell subsets (see the Discussion). In
contrast, cell surface markers such as CD2, CD11a (LFA- TCF-1 Deficiency Results in an NK Cell Autonomous
Defect to Express Ly49A1), CD16/32 (FcgR), CD44, CD45R (B220), CD62L, CD122
(IL-2Rb), 2B4, and DX5 are normally expressed in TCF- To determine whether the failure to acquire Ly49A was
due to defective NK cell precursors or the environment1-deficient splenic NK cells. In addition, receptors en-
coded in the same chromosomal region as Ly49 (CD69, in which they mature, we constructed reciprocal (data
not shown) and mixed bone marrow chimeras (FigureCD164 [NK1.1] and CD94 mRNA) were normally ex-
pressed (data not shown), indicating that TCF-1 defi- 6). Lethally irradiated wild-type mice were reconstituted
with a mixture of wild-type and TCF-1 mutant bone mar-ciency selectively affects Ly49 receptors. Moreover,
interleukin-2 activated NK cells from TCF-12/2 and row cells. In the resulting chimeras, wild-type and TCF-
1-derived B cells were about equally abundant (57.5 6TCF-11/2 mice display normal cytotoxic activity toward
TCF-1-Dependent Ly49A Acquisition
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4.7% of B cells are TCF-1 mutant) indicating the pres- Ly49A acquisition during NK cell development is lim-
ited to a subset of NK cells. One explanation for limitedence of similar numbers of stem cells. Relative to B
cells, TCF-12/2 NK cells and T cells were underrepre- Ly49A acquisition may be that TCF-1 is expressed by a
subset of developing NK cells and its expression directlysented (10- and 64-fold, respectively), most likely re-
flecting a reduced capacity of TCF-12/2 progenitor cells defines NK cells that acquire Ly49A. However, in this
scheme it is difficult to envisage how a reduced TCF-1to expand (Schilham et al., 1998). Importantly, however,
wild-type bone marrow yielded a normal proportion of gene dosage translates into a 2-fold contraction of the
Ly49A subset, unless TCF-1 itself (like Ly49A) would beLy49A-expressing NK cells, while TCF-1 bone marrow
cells that matured in the same environment failed to monoallelically expressed. A recent report has in fact
identified a transcription factor that is subject to thisefficiently produce Ly49A1 NK cells (Figure 6). Ly49A
acquisition thus depends on the presence of TCF-1 in type of regulation (Nutt et al., 1999). However, with re-
gard to TCF-1 we do not find obvious differences inthe developing NK cells. Collectively, the data provide
strong evidence that TCF-1 binding to the Ly49A pro- TCF-1 mRNA levels in Ly49A-positive versus Ly49A-
negative NK cells (data not shown). Moreover, subset-moter is a critical step for the acquisition of the Ly49A
receptor during NK cell development. restricted TCF-1 expression was not observed during T
cell development (Hattori et al., 1996).
Alternatively, based on the reduced Ly49A acquisitionDiscussion
in TCF-1 heterzygous mutant mice, the formation of a
(b-catenin-dependent or -independent) nucleo-proteinThe factors that control Ly49 gene expression and thus
complex at the Ly49A promoter may be inefficient andgenerate clonally diverse Ly49 receptor expression by
TCF-1 binding a rate-limiting event. TCF-1 levels mayNK cells are currently not known. We show here that
allow the assembly of the complex at the Ly49A pro-TCF-1 is required for the acquisition of the Ly49A recep-
moter only occasionally, translating into the stochastictor during NK cell development. This is likely a direct
acquisition of Ly49A by some NK cells. TCF-1 levelseffect as TCF-1 binds to and regulates the Ly49A pro-
would set a probability of Ly49A acquisition on the popu-moter. Clues regarding the mode of TCF-1 action in the
lation level, and modulation of TCF-1 levels would altercontext of the Ly49A promoter are provided by a number
the likelihood of Ly49A acquisition. Restricted Ly49Aof recent findings. On binding site concatemers, TCF-1
acquisition based on limiting TCF-1 availability may ac-has no transactivation capacity by itself, but it acquires
count for an additional feature of Ly49A expression:transcriptional activity upon association with b-cate-
most Ly49A1 NK cells express a single receptor allele.nin (Behrens et al., 1996; Molenaar et al., 1996). TCF/b-
If TCF-1-dependent complex formation occurs only incatenin complexes are formed upon wingless/wnt sig-
occasional NK cells, its concentration in an individualnaling, and their binding to target genes in combination
NK cell may suffice to initiate Ly49A expression onlywith additional transcriptional activators regulates cell
from a single Ly49A allele. The observation that individ-fate decisions (Behrens et al., 1996; Molenaar et al.,
ual NK cells can express either the maternal or the pater-1996; Brannon et al., 1997; Riese et al., 1997). In contrast,
nal (and occasionally both) allele (Held and Raulet,in the TCRa enhancer, TCF-1, like its homolog LEF-1,
performs context-dependent functions, which are inde- 1997a) is consistent with this possibility, as the forma-
tion of the factor complex may occur randomly on eitherpendent of b-catenin binding (van de Wetering et al.,
1996; Hsu et al., 1998). The activity of the TCRa enhancer (and occasionally on both) chromosome.
Besides direct TCF-1-dependent effects on the acqui-is regulated by the collaborative assembly of a higher
order nucleo-protein complex that results from TCF/LEF sition of Ly49A, it is important to consider possible indi-
rect, including selective cellular effects on the Ly49 re-dependent DNA bending (Giese et al., 1995). Similarly,
while the binding of TCF-1 (and/or LEF-1) to the Ly49A ceptor repertoire. These may be based on the specificity
and/or function of the respective receptors. The Ly49G2,promoter is necessary, the presence of intracellular free
b-catenin is not required for the activity of the Ly49A Ly49D (as well as Ly49A) receptors are specific for H-2d
but not H-2b class I molecules (Karlhofer et al., 1992;promoter in EL-4 cells. However, Ly49A promoter activ-
ity is likely to depend on additional tissue-specific fac- Mason et al., 1995; Nakamura et al., 1999). Selective
events based on strong receptor ligand interaction (Heldtors that may cooperate with TCF-1. Indeed, some T cell
lines express TCF-1 but fail to support Ly49A promoter and Raulet, 1997b) are thus unlikely to affect the respec-
tive NK cell subsets in the H-2b haplotype, TCF-1 mutantactivity (Figure 1A). Ly49A promoter function may also
be regulated by LEF-1 since TCF-1 and LEF-1 display mice. The reason for the elevated Ly49G2 representation
remains currently unknown. In contrast, the representa-virtually identical DNA binding specificity, and they per-
form redundant (yet not equally important) functions tion of NK cells expressing self-MHC-specific receptors
(such as Ly49C and Ly49I) is more likely to be subject towith regard to regulating the TCRa enhancer in vitro
(van de Wetering et al., 1996). Thus, LEF-1 may be able cellular events based on receptor specificity. Therefore,
besides Ly49A, TCF-1 deficiency may affect in part theto maintain Ly49A expression in vivo in the absence of
TCF-1. This is based on the normal Ly49A cell surface acquisition of additional Ly49 receptors, such as Ly49D.
It is therefore clear that, besides Ly49A, Ly49 receptorlevels of the occasional Ly49A1 NK cells in TCF-1-defi-
cient mice. In contrast to the constitutive Ly49A expres- acquisition in general is not stringently dependent on
TCF-1. This suggests that the generation of the Ly49sion, Ly49A acquisition is drastically impaired in the
absence of TCF-1. The process of Ly49A acquisition is receptor repertoire depends on multiple trans-acting
factors and thus raises the possibility that the acquisi-likely to be developmentally regulated, and it will be
important to determine whether TCF-1 is required in tion of individual Ly49 receptors is regulated via distinct
pathways, perhaps in response to distinct signals. Thisconjunction with b-catenin.
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Mobility Shift Assaymay explain the discrete appearance of some Ly49 re-
Murine TCF-1 (pM2a) (Oosterwegel et al., 1991) was transcribed andceptors in an adoptive transfer model (Dorfman and
translated in vitro with the TNT T7 coupled reticulocyte lysate systemRaulet, 1998) and account for the observation that Ly49
(Promega). TCF-1 containing lysate (1.5 ml equivalents) was incu-
receptors are coexpressed at frequencies that indicate bated for 2 min on ice with binding buffer (Brannon et al., 1997),
independently regulated events (Held et al., 1996; Raulet followed by a further 30 min incubation with a radio-labeled oligonu-
cleotide probe that contains a consensus TCF binding site (Korineket al., 1997).
et al., 1997) (5 3 104 cpm, 10 fmoles) and analyzed as describedThe importance of TCF-1 points to a role of LEF-1 in
(Brannon et al., 1997). For competition analyses, we used an excessalso regulating Ly49 receptor acquisition. The disruption
of 222 bp (PstI [2178] to EcoRV [144]) Ly49A promoter fragmentof TCF-1 and LEF-1 is required to abolish TCRa gene
that contain both, one, or no TCF sites. TCF sites were eliminated
expression in vivo (Okamura et al., 1998). Therefore, by sequential PCR using the genomic Ly49A clone 9-1 (Kubo et al.,
residual Ly49A1 NK cells in TCF-12/2 mice may arise by 1993) as a template and flanking oligos (at PstI and EcoRV sites)
together with mutated TCF site-specific oligos (only sense oligosthe action of LEF-1. Moreover, based on the incomplete
are shown, sites are underlined, mutations bold). Site I: CTCTTTeffect of the TCF-1 mutation on Ly49D acquisition, it is
TTGATTTGTCGACGAGGAGGAGC Site II: CTTCTCTCCTTTGGCtempting to speculate that clonal acquisition of multiple
CTGAGGGTCAGG.Ly49 receptors is controlled by the combined action of
TCF-1 and LEF-1. Experiments are underway to test this
hypothesis. Transfections and Reporter Gene Assays
The 59 region (-1066 [EcoRI] to 144 [EcoRV]) of the Ly49A geneWe have identified a trans-acting factor that directs
(Kubo et al., 1993) was inserted into the luciferase (luc) reporterclonally variable Ly49A gene expression perhaps via
plasmid pGL3 (Promega). Ten million cells were electroporated withthe limited, stochastic activation of individual receptor
5 mg of the luc plasmid or a promoter-less luc construct. One micro-
alleles. In addition to Ly49, cytokine genes (Bix and gram of a SV40 promoter green fluorescent protein (GFP) plasmid
Locksley, 1998; HollaÈ nder et al., 1998; RivieÁ re et al., was included as a transfection control. After 48 hr, the cells were
1998) as well as TCR and immunoglobulin genes are analyzed for GFP expression using flow cytometry or lysed to mea-
sure luc activity (Promega). The above Ly49A promoter fragmentusually expressed from a single allele. It will be interest-
(EcoRI to EcoRV) and corresponding fragments in which one or bothing to see whether, besides Ly49A and TCRa, TCF/LEF
TCF/LEF sites are mutated (as described above) were cloned intofactors regulate additional genes that are subject to
the luc reporter plasmid pGL3. The constructs were sequenced to
monoallelic expression. ensure that only the intended mutations were introduced. Constructs
for b-catenin expression, b-catenin-TCF/LEF reporter assays (pTOP-
FLASH and control pFOPFLASH) were described before (KorinekExperimental Procedures
et al., 1997). Murine TCF-1 (pM2a) (Oosterwegel et al., 1991) was
subcloned into the pEF Boss expression vector. CotransfectionsMice
were done as above using 2 mg of GFP control plasmid with 2 mgC57BL/6 (B6) (CD45.2) and CD45.1 congenic B6 mice were pur-
of appropriate luc reporter and 9 mg of expression plasmid.chased from HARLAN OLAC (Netherlands) and from Jackson Lab
(Bar Harbor), respectively. TCF-1 (exon VII)±deficient mice (Verbeek
et al., 1995) were back-crossed several times to B6 mice before
RNA Analysisintercrossing. Mice used here were genotyped for TCF-1 and the
Total cellular RNA was obtained from Concanavalin A (ConA) stimu-origin (129/Sv or B6) of the polymorphic NK gene complex (NKC)
lated T cells or interleukin-2 expanded adherent lymphokine ac-that contains Ly49 genes. The latter was done using a restriction
tivated killer (A-LAK) cells using TRIzol (BRL) according to man-fragment length polymorphism (RFLP) between 129/Sv and B6
ufacturers' recommendations. Reverse transcriptase (RT) wasmouse strains (EcoRI-digested genomic DNA probed with a Ly49A
performed as previously described (Held et al., 1993) using oligo dTcDNA) and/or staining of peripheral blood lymphocytes (PBL) with
for priming. Polymerase chain reaction (PCR) was performed usingthe B6-allele-specific mAbs PK136 (NK1.1) or A1 (Ly49A) (Held et
serially diluted cDNAs with primers specific for NKRP-1C (207±680)al., 1995).
(Held and Raulet, 1997b) and Ly49A (145±535) (Held and Kunz, 1998).
PCR reactions used AmpliTaq DNA polymerase (PerkinElmer). Cy-
Bone Marrow Chimeras
cling conditions were 3 min at 928C, 30 cycles at 928C for 1 min,
Recipient TCF-11/1 (CD45.1) mice (8 to 10 weeks old) were injected
558C for 1 min, and 728C for 1 min. PCR products were separated
intraperitoneally with 200 mg of mAb PK136 to deplete NK cells,
through agarose gel electrophoresis, blotted onto nylon mem-
followed by lethal irradiation (950 rads from a 137Cs source). Mice
branes, and hybridized with end-labeled internal Ly49A (59CTG
were reconstituted by intravenous injection of an equal mixture of
TTTCCTTCTTCTGGTAG) and NKRP-1 (59TAGAGTGCCCACAAGA
TCF-11/1 (CD45.1) and TCF-12/2 (CD45.2) Thy 1-depleted bone mar-
CTGC) oligos. Northern blots of 10 mg of cellular RNA were per-
row cells (5 3 106 cells total). Chimeras were analyzed 8±12 weeks
formed using standard techniques. Blots were hybridized with a
following reconstitution.
randomly primed TCF-1 (pM2a) (Oosterwegel et al., 1991) probe,
stripped, and reprobed with GAPDH probes. Signal quantitation was
Flow Cytometry done using a BAS-1000 imager and AIDA software (Fuji).
Spleen and bone marrow cell suspensions were passed over nylon
wool columns, while liver lymphocytes were obtained using a percoll
gradient. Usually, 106 cells were incubated with 24G2 (anti-CD16/ Acknowledgments
32) hybridoma supernatant to reduce background. Cells were further
stained with a mixture of biotinylated DX5, NK1.1-phycoerythrin We thank P. Reichenbach for advice and P. Zaech for expert assis-
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